myeloma

Showing 76 - 100 of 133

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Lymphoma, Myeloma Trial in Chicago (Busulfan, Fludarabine, Campath)

Completed
  • Leukemia
  • +2 more
  • Chicago, Illinois
    The University of Chicago
Feb 1, 2019

Vascular Functions in Myeloma Patients During Anti-tumor Therapy

Unknown status
  • Cardiooncology
  • +2 more
  • Flow mediated dilation
  • (no location specified)
Dec 17, 2018

Myeloma Trial in Houston (Topotecan, Cyclophosphamide, Melphalan)

Completed
  • Myeloma
  • Houston, Texas
    U.T. M.D. Anderson Cancer Center
Nov 6, 2018

Myeloma Trial in Sheffield (Supervised Exercise Program)

Completed
  • Myeloma
  • Supervised Exercise Program
  • Sheffield, South Yorkshire, United Kingdom
    Sheffield Teaching Hospitals NHS Foundation Trust
Oct 25, 2018

Myeloma, Mucositis, Cryotherapy Effect Trial (cryotherapy)

Unknown status
  • Myeloma
  • +2 more
  • cryotherapy
  • (no location specified)
Oct 10, 2018

Myeloma Trial in Baltimore (Lenalidomide, Dexamethasone, and MEDI-551)

Completed
  • Myeloma
  • Lenalidomide, Dexamethasone, and MEDI-551
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center
Sep 6, 2018

Hematologic Diseases, Cachexia; Cancer, Leukemia Trial in Erlangen (whole-body electromyostimulation)

Unknown status
  • Hematologic Diseases
  • +5 more
  • whole-body electromyostimulation
  • Erlangen, Germany
    Department of Medicine 1, Hector Center for Nutrition, Exercise
Jun 4, 2018

Myeloma Trial in Houston (biological, drug, procedure)

Terminated
  • Myeloma
  • KLH Vaccine
  • +4 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 29, 2018

Myeloma Trial (Simvastatin,Zoledronic Acid,Bortezomib,Bendamustine,Methylprednisolone.)

Withdrawn
  • Myeloma
  • Simvastatin,Zoledronic Acid,Bortezomib,Bendamustine,Methylprednisolone.
  • (no location specified)
Dec 27, 2017

Lymphoma, Myeloma, Leukemia Trial in Juiz De Fora (Inspiratory Muscle Training, Aerobic Training)

Unknown status
  • Lymphoma
  • +3 more
  • Inspiratory Muscle Training
  • Aerobic Training
  • Juiz De Fora, Minas Gerais, Brazil
    University Hospital-EBSERH
Dec 14, 2017

Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin, Myeloma Trial in Monterrey (Plerixafor 0.12 mg/kg)

Unknown status
  • Lymphoma, Non-Hodgkin
  • +3 more
  • Plerixafor 0.12 mg/kg
  • Monterrey, Nuevo Leon, Mexico
    Servicio de Hematología Hospital Universitario "Dr. José Eleuter
Aug 9, 2017

Myeloma Trial in United States (Bendamustine, Lenalidomide, Dexamethasone)

Completed
  • Myeloma
  • Detroit, Michigan
  • +21 more
Jul 26, 2017

GVHD, Leukemia, Lymphoma Trial in Boston, Minneapolis (drug, procedure, radiation)

Completed
  • Graft Versus Host Disease
  • +4 more
  • Boston, Massachusetts
  • +1 more
Mar 30, 2017

MDS, Myeloproliferative Disorders, Leukemia, Lymphocytic Trial in Tampa (Busulfan, Fludarabine)

Completed
  • Myelodysplastic Syndromes
  • +4 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 20, 2017

Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (radiation, biological, drug)

Terminated
  • Hematologic Malignancy
  • +11 more
  • Total Body Irradiation (TBI)
  • +5 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Oct 19, 2016

Hematologic Malignancies, Acute Leukemia, MDS (MDS) Other Than RA or RARS Subtypes Trial in Philadelphia (drug, radiation,

Terminated
  • Hematologic Malignancies
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Nov 28, 2016

Lymphoma, Myeloma, Peripheral Neuropathy Trial in Houston (Acupuncture)

Completed
  • Lymphoma
  • +2 more
  • Acupuncture
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 14, 2016

Hematologic Diseases, Leukemia, Lymphoma Trial in Houston (Busulfan, Fludarabine, Cyclophosphamide)

Completed
  • Hematologic Diseases
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 28, 2016

Myeloma Trial in Houston (Lenalidomide, Dexamethasone, All-Trans Retinoic Acid (ATRA))

Terminated
  • Myeloma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 12, 2016

Cancer, Myeloma, Multiple Myeloma Trial in Salt Lake City (Bortezomib)

Terminated
  • Cancer
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jul 7, 2016

Lymphoma, Myeloma, Leukemia Trial in Durham (Campath Purged Non-myeloablative ASCT)

Completed
  • Lymphoma
  • +4 more
  • Campath Purged Non-myeloablative ASCT
  • Durham, North Carolina
    Duke University Health Systems
May 23, 2016

Leukemia, Lymphoma, Myeloma Trial in Toronto (NK-92 cells)

Completed
  • Leukemia
  • +3 more
  • NK-92 cells
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Jun 21, 2016

Myeloma Trial in New Haven (Lenalidomide, Monocyte derived DCs loaded with KRN7000)

Completed
  • Myeloma
  • New Haven, Connecticut
    Yale University School of Medicine
Jun 20, 2016

Myeloma, Stem Cell Transplantation Trial in Houston (Lenalidomide, Melphalan, Stem Cell Infusion)

Completed
  • Myeloma
  • Stem Cell Transplantation
  • Houston, Texas
    UT MD Anderson Cancer Center
May 5, 2016